Trademark: 90722349
Word
COBALT
Status
Pending
Status Code
732
Status Date
Monday, August 28, 2023
Serial Number
90722349
Mark Type
4000
Filing Date
Wednesday, May 19, 2021
Published for Opposition
Tuesday, February 22, 2022

Trademark Owner History
Crispr Therapeutics AG - Owner At Publication

Classifications
5 Cells for medical or clinical use; Pharmaceutical preparations being pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, pharmaceutical preparations being gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer
42 Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development

Trademark Events
Aug 30, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 28, 2023
Sou Extension 3 Granted
Aug 28, 2023
Sou Extension 3 Filed
Aug 28, 2023
Sou Teas Extension Received
Mar 17, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 15, 2023
Sou Extension 2 Granted
Mar 15, 2023
Sou Extension 2 Filed
Mar 15, 2023
Sou Teas Extension Received
Oct 5, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 3, 2022
Sou Extension 1 Granted
Oct 3, 2022
Sou Extension 1 Filed
Oct 3, 2022
Sou Teas Extension Received
Apr 19, 2022
Noa E-Mailed - Sou Required From Applicant
Feb 22, 2022
Official Gazette Publication Confirmation E-Mailed
Feb 22, 2022
Published For Opposition
Feb 2, 2022
Notification Of Notice Of Publication E-Mailed
Jan 19, 2022
Approved For Pub - Principal Register
Jan 19, 2022
Examiner's Amendment Entered
Jan 19, 2022
Notification Of Examiners Amendment E-Mailed
Jan 19, 2022
Examiners Amendment E-Mailed
Jan 19, 2022
Examiners Amendment -Written
Jan 11, 2022
Assigned To Examiner
Aug 17, 2021
New Application Office Supplied Data Entered
May 22, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24